Utilization and Reporting of Patient-Reported Outcome Measures in Randomized Clinical Trials of Acute Stroke (2010–2020)
Stroke Journal
MARCH 21, 2024
Stroke, Ahead of Print. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain. Eligible studies were phase 2 or 3 trials that tested therapeutic interventions within 1 month of stroke onset.
Let's personalize your content